Articles published in Journal of Pharmacogenomics & Pharmacoproteomics have been cited by esteemed scholars and scientists all around the world. Journal of Pharmacogenomics & Pharmacoproteomics has got h-index 12, which means every article in Journal of Pharmacogenomics & Pharmacoproteomics has got 12 average citations.

Following are the list of articles that have cited the articles published in Journal of Pharmacogenomics & Pharmacoproteomics.

  2022 2021 2020 2019 2018

Year wise published articles

30 30 13 4 7

Year wise citations received

59 69 60 48 62
Journal total citations count 548
Journal Impact Factor 2.31
Journal 5 years Impact Factor 3.74
Journal CiteScore 4.86
Journal h-index 12
Important citations

Regulation of somatostatin receptor 4-mediated cytostatic effects by CD26 in malignant pleural mesothelioma

Ispitivanje zna?aja polimorfizama gena za citokine i proteine koji regulišu metabolizam i transport imunosupresivnih lekova u akutnom odbacivanju transplantiranog bubrega

Towards next-generation personalization of tacrolimus treatment: a review on advanced diagnostic and therapeutic approaches

CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy

Pharmacogenomics research and clinical implementation in Brazil

?????? ???????? Lancet ?? ???????? ??????????? ???????????? ???????? ? ??????????? ????????

The Lancet Commission on global mental health and sustainable development

Pioneering Function of Isl1 in Epigenetic Regulation During Second Heart Field Development

Differential CpG DNA methylation in peripheral naïve CD4+ T-cells in early rheumatoid arthritis patients

The Lancet Commission on global mental health and sustainable development

Análisis de los factores asociados a la susceptibilidad a fumar en estudiantes de educación secundaria del proyecto motiva educación secundaria del proyecto motivo EDUCA

Tobacco-You are never too Old to Quit

Pediatric Infectious Diseases

 Quit Smoke or Quit Your Life With Stroke!

Alzheimer ’ s Disease and Glucose Metabolism

Novel indications for benzodiazepine antagonist flumazenil in GABA mediated pathological conditions of the central nervous system

Flumazenil for the treatment of refractory hypersomnolence: clinical experience with 153 patients

A study on the genetic polymorphisms of CYP3A5 among the Orang Asli in Malaysia using a next generation sequencing platform

In silico genetic variation analysis of cytochrome P450 2c19 and their effect in certain drugs metabolism

A study of CYP2C19* 2,* 3 and* 7 in different Sudanese ethnic groups and their response to omeprazole based triple therapy in Khartoum, Sudan 2016-2017.